Presentations

How to select the Most Appropriate Device for CAS?

solaci
solaci
536
0

17_mendiz_oscar

Oscar Mendiz
2014-04-22

Head Interventional Cardiology Department
Board of Directors Members
Hospital & Favaloro University

Previous article
Enfermedad Carotídea: Indicaciones de Tratamiento Endovascular. Pacientes Asintomaticos
Next article
Tratamiento percutáneo del TCI y Bifurcaciones. Indicación Clínica del tratamiento
solaci
solaci

More articles by this author

Transcatheter Aortic Valve Implantation: Step by Step

solaci - 0
Daniel Chamié2014-04-22Instituto Dante Pazzanese de CardiologiaSão Paulo – Brasil   

Implante transcateter de bioprótesis aórtica. Selección de pacientes

solaci - 0
Jorge Belardi2014-04-22Director del Departamento de Cardiología ICBA

Implante Transapical de Bioprotesis Aórtica Autoexpandible en Paciente Compasivo con Estenosis Aórtica Severa contraindicado para otros abordajes

solaci - 0
Cohen Fernando2014-04-22Servicio de Hemodinamia y Cardiología IntervencionistaHospital Italiano de Buenos Aires

Cierre de Orejuela Auricular Izquierda: Técnica y Resultados

solaci - 0
Aníbal Damonte2014-04-22Departamento de Hemodinamia y Cardiología IntervencionistaInstituto Cardiovascular de RosarioRosario, Argentina

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Presentations

Transcatheter Aortic Valve Implantation: Step by Step

Daniel Chamié2014-04-22Instituto Dante Pazzanese de CardiologiaSão Paulo – Brasil   
solaci -
SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage Closure

Dr. Andrés Rodríguez - 0
Percutaneous left atrial appendage (LAA) closure is an alternative therapeutic strategy for reducing the risk of stroke in patients with atrial fibrillation (AF). Randomized...

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

Dr. Andrés Rodríguez - 0
According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

Dr. Andrés Rodríguez - 0
The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...